Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 33 n° 348

Posts Tagged ‘financial result’

Halo Labs Reports Financial Results for Fourth Quarter and Year End December 31, 2019

Posted by fidest press agency su martedì, 21 aprile 2020

Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) today announced its 2019 financial and operational results. The Company reported revenues of $28.1 million for the year ended December 31, 2019, a 158% increase in comparison with the previous year. Adjusted gross profit was $5.3 million, excluding fair value gains in biological assets, impairment of inventory and non-reoccurring costs due to market circumstances in the fourth quarter in 2019. The adjusted gross margin in 2019 was 19% in comparison with -1% in 2018. Complete results are reported in the Company’s consolidated financial statements for the year ended December 31, 2019 and associated management discussion and analysis (the “MD&A”).Market circumstances across the Company’s two core markets in the fourth quarter materially affected financial results. On September 26, 2019, in response to the emerging health crisis tied to nicotine and cannabis vaping products, the Oregon Health Authority (OHA) issued a public health advisory and on October 4, 2019, Oregon’s Governor, Kate Brown, took the OHA warning a step further and issued an executive order immediately banning flavored cannabis vaping products, including cannabis vape cartridges, for 180 days. At the same time, California Governor Gavin Newsom and the California Department of Public Health (CDPH) advised all Californians to stop vaping until the root cause for the lung illness was pinpointed. The Governor Newsom’s order also required stores selling vaping devices to post warnings about the health risks of those products. BDS analytics found that vape product sales declined sharply through the end of 2019. Using data across Arizona, California, Colorado, Nevada and Oregon, sales had plummeted approximately 25% by October with additional declines expected throughout Q4. While revenue in 2019 fell below management’s initial expectations, when faced with several challenging market and regulatory dynamics Halo elected to forgo revenues that would cause the business to draw heavily upon cash reserves and thus strengthened Halo’s financial position relative to the industry as a whole. The Company had working capital of $15.3 million at December 31, 2019 compared with $6.2 million in 2018. At December 31, 2019, the Company had cash of $6.1 million, of which $1.7 million was restricted. The Company’s large inventory balances have been critical during the Covid-19 pandemic given supply chain disruptions experienced worldwide.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Limelight Networks, Inc. to Issue Second Quarter 2018 Financial Results

Posted by fidest press agency su sabato, 30 giugno 2018

Limelight Networks, Inc. (Nasdaq:LLNW) will report financial results for the second quarter of 2018 on Thursday, July 19, 2018 at 4:00 p.m. EDT (1:00 p.m. PDT).Management will host a quarterly conference call for investors at 4:30 p.m. EDT (1:30 p.m. PDT). Investors can access this call toll-free at (877) 296-5190 within the United States or +1 (412) 317-5233 outside of the United States.The conference call will also be audio cast live from http://investors.limelight.com/ and a replay will be available following the call from the Company’s website. Limelight Networks, a global leader in digital content delivery, empowers customers to better engage online audiences by enabling them to securely manage and globally deliver digital content, on any device. The company’s Limelight Orchestrate Platform includes a global infrastructure with a fully-integrated suite of capabilities and services to help you address all your content delivery needs. The Orchestrate Platform solves your most important content delivery challenges so you can deliver the next great digital experience anywhere. For more information, please visit http://www.limelight.com and follow us on Twitter, Facebook and LinkedIn.

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »

Teva to Report Third Quarter 2017 Financial Results

Posted by fidest press agency su giovedì, 12 ottobre 2017

Teva_PharmaceuticalTeva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it will release its third quarter 2017 financial results on Thursday, November 2, 2017 at 7:00 a.m. ET.Teva will host a conference call and live webcast on the same day, at 8:00 a.m. ET to discuss its third quarter 2017 results and overall business environment. A Question & Answer session will follow this discussion.
In order to participate, please dial the following numbers (at least 10 minutes before the scheduled start time): United States 1-866-869-2321; Canada 1-866-766-8269 or International +44(0) 203 0095710; passcode: 91932782. For a list of other international toll-free numbers, click here.A live webcast of the call will also be available on Teva’s website at: http://www.ir.tevapharm.com Please log in at least 10 minutes prior to the conference call in order to download the applicable audio software.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions used by approximately 200 million patients in 100 markets every day. Headquartered in Israel, Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,800 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has the world-leading innovative treatment for multiple sclerosis as well as late-stage development programs for other disorders of the central nervous system, including movement disorders, migraine, pain and neurodegenerative conditions, as well as a broad portfolio of respiratory products. Teva is leveraging its generics and specialty capabilities in order to seek new ways of addressing unmet patient needs by combining drug development with devices, services and technologies. Teva’s net revenues in 2016 were $21.9 billion. For more information, visit http://www.tevapharm.com.

Posted in Economia/Economy/finance/business/technology, Spazio aperto/open space | Contrassegnato da tag: , , | Leave a Comment »